- Home
- CLS vs ASND Comparison
CLS vs ASND Comparison
Compare CLS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLS
- ASND
- Stock Information
- Founded
- CLS 1994
- ASND 2006
- Country
- CLS Canada
- ASND Denmark
- Employees
- CLS N/A
- ASND N/A
- Industry
- CLS Electrical Products
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CLS Technology
- ASND Health Care
- Exchange
- CLS Nasdaq
- ASND Nasdaq
- Market Cap
- CLS 9.7B
- ASND 10.6B
- IPO Year
- CLS 1998
- ASND 2015
- Fundamental
- Price
- CLS $160.98
- ASND $175.45
- Analyst Decision
- CLS Strong Buy
- ASND Strong Buy
- Analyst Count
- CLS 9
- ASND 17
- Target Price
- CLS $117.00
- ASND $222.18
- AVG Volume (30 Days)
- CLS 3.4M
- ASND 429.4K
- Earning Date
- CLS 07-28-2025
- ASND 09-02-2025
- Dividend Yield
- CLS N/A
- ASND N/A
- EPS Growth
- CLS 37.60
- ASND N/A
- EPS
- CLS 3.58
- ASND N/A
- Revenue
- CLS $10,085,700,000.00
- ASND $398,509,511.00
- Revenue This Year
- CLS $14.34
- ASND $77.19
- Revenue Next Year
- CLS $16.83
- ASND $75.84
- P/E Ratio
- CLS $43.83
- ASND N/A
- Revenue Growth
- CLS 21.05
- ASND 12.06
- 52 Week Low
- CLS $40.25
- ASND $111.09
- 52 Week High
- CLS $163.95
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- CLS 70.97
- ASND 54.14
- Support Level
- CLS $152.92
- ASND $168.01
- Resistance Level
- CLS $163.95
- ASND $180.00
- Average True Range (ATR)
- CLS 6.83
- ASND 6.12
- MACD
- CLS 0.12
- ASND -0.28
- Stochastic Oscillator
- CLS 91.07
- ASND 59.33
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.